Collegium Participate in Upcoming Conferences
Get Alerts COLL Hot Sheet
Join SI Premium – FREE
STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences:
Jefferies London Healthcare ConferenceVirtual one-on-one meetingsDate: Thursday, November 18, 2021
Piper Sandler Annual Healthcare Conference 2021Virtual fireside chatDate: Wednesday, December 1, 2021
The fireside chat will be webcast and may be accessed from the Investor section of the Company’s website: https://ir.collegiumpharma.com. A replay of the webcast will be available on the Company’s website for approximately 30 days after the event.
About Collegium Pharmaceutical, Inc.
Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact: MacDougall Advisors [email protected]Source: Collegium Pharmaceutical, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pure DC Launches One of Europe’s Largest Ever AI Infrastructure Projects: Phase 1 (110MW) of an over €7.5 Billion, 550MW AI Campus in Seinäjoki, Begins Fully Leased, with Planning & Power Already
- Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury
- Pure DC Launches One of Europe’s Largest Ever AI Infrastructure Projects: Phase 1 (110MW) of an over €7.5 Billion, 550MW AI Campus in Seinäjoki, Begins Fully Leased, with Planning & Power Alr
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share